Your browser doesn't support javascript.
Impact of a reduced nicotine standard on young adult appeal for menthol and non-menthol cigarettes.
Cohn, Amy M; Cassidy, Rachel; Denlinger-Apte, Rachel; Donny, Eric; Villanti, Andrea C; Hatsukami, Dorothy; Dunn, Delaney; Wyatt, Riley; Niznik, Taylor; Cohen-Davidyan, Tamar; Smith, Michael; Ehlke, Sarah J.
  • Cohn AM; Department of Pediatrics, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA amy-cohn@ouhsc.edu.
  • Cassidy R; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Denlinger-Apte R; Center for Alcohol & Addiction Studies, Brown University, Providence, Rhode Island, USA.
  • Donny E; Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Villanti AC; Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Hatsukami D; Health Behavior, Society & Policy, Deparment of Health Behavior, Rutgers Center for Tobacco Studies, School of Public Health, Rutgers University, New Brunswick, New Jersey, USA.
  • Dunn D; Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota, USA.
  • Wyatt R; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Niznik T; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Cohen-Davidyan T; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Smith M; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Ehlke SJ; TSET Health Promotion Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
BMJ Open ; 12(11): e067694, 2022 11 21.
Article in English | MEDLINE | ID: covidwho-2193803
ABSTRACT

INTRODUCTION:

The Food and Drug Administration (FDA) announced its intention to reduce the nicotine content in cigarettes as a strategy to promote cessation and reduce smoking-related harm. A low nicotine product standard will apply to all cigarettes on the market, including menthol cigarettes. In December 2021, the FDA approved a modified risk tobacco product application for menthol and non-menthol flavoured very low nicotine cigarettes (VLNC) from the 22nd Century Group. Notably, experimentation with menthol cigarettes is linked to smoking progression, as well as greater nicotine dependence relative to non-menthol cigarette use. If menthol VLNCs are perceived as more appealing than non-menthol VLNCs, this would indicate that some aspect of menthol may maintain smoking even in the absence of nicotine and FDA's regulatory authority to ban or restrict the sale of menthol cigarettes should apply to reduced nicotine content of cigarettes. In April 2022, the FDA announced proposed rulemaking to prohibit menthol cigarettes, however it is unclear if a menthol prohibition would apply to VLNCs. METHODS AND

ANALYSIS:

This study will recruit 172 young adult menthol smokers (with a specific subsample of n=40 sexual and gender minority young adults) and measure appeal for smoking experimental menthol and non-menthol VLNCs, and the impact of proposed product standards on tobacco product purchasing behaviour using an Experimental Tobacco Marketplace. Appeal across product standards will be assessed in a controlled laboratory and using ecological momentary assessment. ETHICS AND DISSEMINATION The protocol was approved by the University of Oklahoma Health Sciences Center Institutional Review Board (#11865). Findings will examine the effects of a reduced nicotine standard and a menthol ban on young adult smoking and will be disseminated through peer-reviewed journal articles and presentations at scientific conferences. TRIAL REGISTRATION NUMBER NCT04340947.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tobacco Use Disorder / Tobacco Products Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Young adult Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2022-067694

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tobacco Use Disorder / Tobacco Products Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Young adult Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2022-067694